BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19083199)

  • 1. Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomised, double-blind, placebo-controlled trial.
    Knight DJ; Gardiner D; Banks A; Snape SE; Weston VC; Bengmark S; Girling KJ
    Intensive Care Med; 2009 May; 35(5):854-61. PubMed ID: 19083199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a Probiotic Preparation on Ventilator-Associated Pneumonia in Critically Ill Patients Admitted to the Intensive Care Unit: A Prospective Double-Blind Randomized Controlled Trial.
    Mahmoodpoor A; Hamishehkar H; Asghari R; Abri R; Shadvar K; Sanaie S
    Nutr Clin Pract; 2019 Feb; 34(1):156-162. PubMed ID: 30088841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients: A Randomized Clinical Trial.
    Johnstone J; Meade M; Lauzier F; Marshall J; Duan E; Dionne J; Arabi YM; Heels-Ansdell D; Thabane L; Lamarche D; Surette M; Zytaruk N; Mehta S; Dodek P; McIntyre L; English S; Rochwerg B; Karachi T; Henderson W; Wood G; Ovakim D; Herridge M; Granton J; Wilcox ME; Goffi A; Stelfox HT; Niven D; Muscedere J; Lamontagne F; D'Aragon F; St-Arnaud C; Ball I; Nagpal D; Girard M; Aslanian P; Charbonney E; Williamson D; Sligl W; Friedrich J; Adhikari NK; Marquis F; Archambault P; Khwaja K; Kristof A; Kutsogiannis J; Zarychanski R; Paunovic B; Reeve B; Lellouche F; Hosek P; Tsang J; Binnie A; Trop S; Loubani O; Hall R; Cirone R; Reynolds S; Lysecki P; Golan E; Cartin-Ceba R; Taylor R; Cook D;
    JAMA; 2021 Sep; 326(11):1024-1033. PubMed ID: 34546300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synbiotics modulate gut microbiota and reduce enteritis and ventilator-associated pneumonia in patients with sepsis: a randomized controlled trial.
    Shimizu K; Yamada T; Ogura H; Mohri T; Kiguchi T; Fujimi S; Asahara T; Yamada T; Ojima M; Ikeda M; Shimazu T
    Crit Care; 2018 Sep; 22(1):239. PubMed ID: 30261905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial.
    Jain PK; McNaught CE; Anderson AD; MacFie J; Mitchell CJ
    Clin Nutr; 2004 Aug; 23(4):467-75. PubMed ID: 15297081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of probiotics or synbiotics in critically ill patients: A systematic review and meta-analysis.
    Lou J; Cui S; Huang N; Jin G; Chen C; Fan Y; Zhang C; Li J
    Clin Nutr ESPEN; 2024 Feb; 59():48-62. PubMed ID: 38220407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia.
    Shi Z; Xie H; Wang P; Zhang Q; Wu Y; Chen E; Ng L; Worthington HV; Needleman I; Furness S
    Cochrane Database Syst Rev; 2013 Aug; (8):CD008367. PubMed ID: 23939759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotic prophylaxis to prevent ventilator associated pneumonia (VAP) in children on mechanical ventilation: an open-label randomized controlled trial.
    Banupriya B; Biswal N; Srinivasaraghavan R; Narayanan P; Mandal J
    Intensive Care Med; 2015 Apr; 41(4):677-85. PubMed ID: 25708419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral mucosal mouthwash with chlorhexidine does not reduce the incidence of ventilator-associated pneumonia in critically ill children: A randomised controlled trial.
    Karakaya Z; Duyu M; Yersel MN
    Aust Crit Care; 2022 Jul; 35(4):336-344. PubMed ID: 34376358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotic in the prevention of ventilator-associated pneumonia in critically ill patients: evidence from meta-analysis and trial sequential analysis of randomized clinical trials.
    Sun YC; Wang CY; Wang HL; Yuan Y; Lu JH; Zhong L
    BMC Pulm Med; 2022 Apr; 22(1):168. PubMed ID: 35484547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating probiotics for the prevention of ventilator-associated pneumonia: a randomised placebo-controlled multicentre trial protocol and statistical analysis plan for PROSPECT.
    Johnstone J; Heels-Ansdell D; Thabane L; Meade M; Marshall J; Lauzier F; Duan EH; Zytaruk N; Lamarche D; Surette M; Cook DJ;
    BMJ Open; 2019 Jun; 9(6):e025228. PubMed ID: 31227528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial.
    Morrow LE; Kollef MH; Casale TB
    Am J Respir Crit Care Med; 2010 Oct; 182(8):1058-64. PubMed ID: 20522788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis.
    Manzanares W; Lemieux M; Langlois PL; Wischmeyer PE
    Crit Care; 2016 Aug; 19():262. PubMed ID: 27538711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled study of probiotics containing Lactobacillus casei (Shirota strain) for prevention of ventilator-associated pneumonia.
    J Med Assoc Thai; 2015 Mar; 98(3):253-9. PubMed ID: 25920295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Synbiotics in the Prevention of Ventilator-Associated Pneumonia: A Randomized, Triple-Blind, Placebo-Controlled Clinical Trial.
    Kasiri F; Soltani R; Khorvash F; Ataei B; Nasirian M; Hakamifard A
    Int J Prev Med; 2023; 14():124. PubMed ID: 38264562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of ventilator-associated pneumonia on the Canadian health care system.
    Muscedere JG; Martin CM; Heyland DK
    J Crit Care; 2008 Mar; 23(1):5-10. PubMed ID: 18359415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the effect of oral synbiotic on enteral feeding tolerance in critically ill patients: A double-blinded controlled clinical trial of gut microbiota.
    Dehghani MH; Saghafi F; Bordbari Z; Zare-Kamali J; Jafari-Nedooshan J; Sahebnasagh A
    Nutr Clin Pract; 2023 Apr; 38(2):402-410. PubMed ID: 35809224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial.
    François B; Jafri HS; Chastre J; Sánchez-García M; Eggimann P; Dequin PF; Huberlant V; Viña Soria L; Boulain T; Bretonnière C; Pugin J; Trenado J; Hernandez Padilla AC; Ali O; Shoemaker K; Ren P; Coenjaerts FE; Ruzin A; Barraud O; Timbermont L; Lammens C; Pierre V; Wu Y; Vignaud J; Colbert S; Bellamy T; Esser MT; Dubovsky F; Bonten MJ; Goossens H; Laterre PF;
    Lancet Infect Dis; 2021 Sep; 21(9):1313-1323. PubMed ID: 33894131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically Ill trauma patients: early results of a randomized controlled trial.
    Kotzampassi K; Giamarellos-Bourboulis EJ; Voudouris A; Kazamias P; Eleftheriadis E
    World J Surg; 2006 Oct; 30(10):1848-55. PubMed ID: 16983476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotics for the Prevention of Ventilator-Associated Pneumonia: An Updated Systematic Review and Meta-Analysis of Randomised Controlled Trials.
    Cheema HA; Shahid A; Ayyan M; Mustafa B; Zahid A; Fatima M; Ehsan M; Athar F; Duric N; Szakmany T
    Nutrients; 2022 Apr; 14(8):. PubMed ID: 35458162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.